Objective: Arteriovenous fistulas and grafts may often be associated with localized complications related to aneurysms/ pseudoaneurysms, buttonholes, or structural defects that require proper management to ensure continued access functionality for hemodialysis. Partial aneurysmectomy and repair (PAR) is a targeted surgical approach specifically designed for managing these complications. The basic concepts of PAR include resecting unhealthy or excessive tissue over an access, reconstructing the vascular access lumen using in situ vascular wall or tissue when possible, and closing overlying skin with healthy margins to promote reliable healing. This report analyzes the clinical outcomes of PAR in a large clinical series.
Arteriovenous fistulas and grafts are preferred vascular access options over catheters for hemodialysis therapy according to National Kidney Foundation Kidney Disease Outcomes Quality Initiative and Society for Vascular Surgery guidelines. 1, 2 However, fistulas and grafts may often be associated with various complications that require proper management to ensure continued access functionality for hemodialysis. 3 A subset of arteriovenous access complications is related to localized structural changes or integrity compromises: aneurysms, pseudoaneurysms, buttonholes, 4, 5 or structural defects.
These changes may result in bleeding or pose danger for bleeding, infection, or other complications that may contribute to access dysfunction, access loss, and even patient death. 3, [6] [7] [8] These complications usually require surgical or endovascular interventions to achieve reliable clinical outcomes. Although various approaches have been used for managing these complications, 6, 7 accesses are often ligated, especially when the integrity of their structures is compromised. 7, 8 It is important to realize that these accesses can usually be saved when proper management is applied. A key feature of this subset of complications is the localized nature of their pathology, making targeted surgical therapy possible and desirable. Partial aneurysmectomy and repair (PAR) is a targeted surgical approach specifically designed for managing these complications. The basic concepts of PAR include resecting unhealthy or excessive tissue over an access, reconstructing the vascular access lumen using in situ vascular wall or tissue when possible, and closing overlying skin with healthy margins to promote reliable healing. Many clinical reports have demonstrated the concept of using native tissues for managing fistula aneurysms and related complications. 6, [9] [10] [11] [12] [13] [14] Since the initial report of the outcomes of 36 fistula aneurysm repairs using the PAR approach several years ago, 6 we have accumulated more extensive clinical experience using PAR for managing the complications of both arteriovenous fistulas and grafts. This report analyzes the long-term outcomes of our large series and discusses some clinical considerations of using PAR.
METHODS
Setting and patients. This series included 220 PAR operations performed in 209 patients, 185 with arteriovenous fistulas and 24 with grafts, from September 2009 to December 2016 in an ambulatory surgery center specialized in dialysis access care. Also included were 36 previously reported patients for whom longer follow-up was available. 6 All operations in this series were performed by one of the authors (S.W.). Informed consent was obtained from patients before surgery. The Western Institutional Review Board (Puyallup, Wash) approved the study protocol.
Preoperative assessments. Besides assessments of patients' general conditions, focused assessments of the dialysis accesses were performed on the day of surgery for urgent cases or as a separate encounter for elective cases, which included a combination of history, physical examination, duplex Doppler ultrasound evaluation, and review of prior interventions. The duplex Doppler ultrasound evaluation included arterial inflow and venous outflow anatomies as well as the volume flow and hemodynamics of the access conduit. A management plan was chosen after these assessments: surgical repair only if there was no concern of the access circulation, or endovascular intervention before or at the time of repair surgery if there were concerns of an access circulation or clinical indications of access dysfunction for hemodialysis. Flow reduction was indicated when a fistula was still pressurized after proper intervention for the outflow stenosis and the access flow was >2000 mL/min. Surgical procedures. All PAR operations were performed under conscious sedation (midazolam and fentanyl) and local anesthesia (1% lidocaine). Operations were rarely canceled unless a patient had systemic infections or was in an unstable state (low blood pressure, significant arrhythmia, respiratory distress, chest pain, altered mental status). Prophylactic intravenous antibiotics (2 g cephazolin or 1 g vancomycin) were given preoperatively.
For most patients, a pneumatic tourniquet was applied on the upper arm to achieve hemostasis that facilitated the operation (Table I) . For upper arm accesses, a narrower tourniquet cuff (3 or 3.5 inches wide) was applied over the proximal half of the upper arm, leaving the distal half exposed. Most lesions of the upper arm accesses were located in the distal half of the upper arm where the accesses were typically cannulated for hemodialysis. The tourniquet was well tolerated under conscious sedation when the continuous inflation time was limited to <30 minutes, which was sufficient time for repairing of the vascular lumen. 15 When applying a pneumatic tourniquet was not feasible, other methods used for controlling the access circulation included endovascular balloon occlusion, Esmarch elastic bandage occlusion of the arterial circulation at the elbow, or occasionally, direct manual compression of an arteriovenous access or cutdown occlusion using vascular clamps or loops. The arteriovenous fistula aneurysm repairs included resecting unhealthy and excessive tissues of the fistula aneurysms, reconstructing the vascular access lumen using in situ vascular wall with nonabsorbable sutures, and closing overlying skin with healthy margins to promote reliable healing (Fig 1) . The removal of diseased tissues to produce healthy margins was crucial for promoting primary tissue healing after repair. There were almost always adequate adjacent tissues for primary closure after resection of diseased tissues.
For repairs of buttonholes or other tissue defects over a minimally dilated fistula, PAR included resection of diseased (scarred, necrotic) skin, suture repair of the vascular wall, and closure of overlying skin with healthy margins. For arteriovenous graft repairs, PAR included resection of diseased (scarred, necrotic) skin, reconstruction of the graft lumen with existing graft wall (adjacent fibrous tissue could be included between sutures to enhance hemostasis) or autogenous/prosthetic patch, and closure of overlying skin with healthy margins (Fig 2) .
Occasionally, a patient presented with multiple fistula aneurysms that required surgical repairs. PAR in these patients was performed in stages in order to leave enough fistula areas for dialysis cannulations. The 
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Recommendation:
The authors suggest that treatment of aneurysms, pseudoaneurysms, and defects involving arteriovenous fistulas and grafts using partial aneurysmectomy and repair yields excellent results and is the preferred method of treatment.
aneurysms of greater concern (larger, with thinner tissues or erosions) were repaired first. When this strategy was used, a dialysis catheter was rarely needed to continue hemodialysis (Tables I and II) .
Follow-up assessments and interventions. After PAR, instructions were given to the dialysis units to use less heparin during hemodialysis for the first week to minimize the risk of bleeding. One or two additional doses 
Fig 1.
A representative case of arteriovenous fistula aneurysm repair. A, An aneurysm along a forearm fistula developed skin thinning and intermittent bleeding. B, The margin of the scarred unhealthy skin area was marked, and an incision was made along the marking line. C, A pneumatic tourniquet was inflated on the upper arm to control the blood circulation before the excessive fistula wall was resected. The resected tissue was displayed on the right with the endovascular surface facing up. D, The fistula lumen was reconstructed with nonabsorbable sutures, followed by release of the pneumatic tourniquet. Excessive subcutaneous tissue under the lateral skin was trimmed to minimize tissue thickness after incision closure. E, The incision was closed with intermittent and continuous sutures. F, At 6 weeks after the repair, the skin scar was barely noticeable (arrowheads).
of antibiotics (2 g cephazolin or 500 mg vancomycin) were given with dialysis after graft repairs or less sterile fistula repairs, and three to six additional doses of antibiotics were given when there was evidence of localized infections.
The first postoperative visit occurred #1 to 2 weeks to assess the incision healing. The sutures were typically removed 2 weeks after repair. A duplex Doppler ultrasound evaluation of the access conduit was performed 4 to 6 weeks after PAR to assess whether the repaired area was ready for cannulation. Subsequent visits were scheduled at intervals of 3 to 12 months. For these follow-up visits, a combination of access-targeted history, physical examination, and ultrasound evaluation was used.
The indications for fistulogram and treatment of stenosis were based on a combination of clinical indicators and image study findings. The clinical indicators A representative case of arteriovenous graft repair. A, A necrotic tissue/thrombus plug developed in the cannulation zone of a graft. B, Two endovascular balloons were inserted through vascular sheaths and inflated to control the circulation of the graft. The necrotic area was resected to achieve healthy skin margins. C, The graft was flushed with saline before its defect was closed using the remaining graft and surrounding soft tissue. The resected tissue was displayed at the left lower corner of panel C, with the endovascular surface facing up. D, The incision was closed with intermittent sutures. included reduced access flow, prolonged access bleeding after dialysis, infiltration, elevated venous pressure, arm edema, access thrombosis, ischemic symptoms, and other clinical concerns. When indicated, endovascular interventions (balloon angioplasties with occasional stent graft placements) were performed for stenoses of >50% that were associated with clinical indicators.
Data collection and statistical analyses. Relevant clinical data were collected through retrospective review of patient medical records or prospective recordings. Statistics were conducted using SSPS 24 software (IBM, Armonk, NY). Data are presented as mean 6 1 standard deviation for continuous variables and as percentages or ratios for categoric variables.
Kaplan-Meier survival analysis was used to estimate the access patency rates. 16 For the whole access conduit (including the vasculatures from the arteriovenous anastomosis to the right atrium), primary patency was defined as the interval from the time of the repair operation to any intervention designed to maintain the patency of the access or the time of patency measurement. Assisted primary patency was defined as the interval from the time of the repair operation to access thrombosis/abandonment or time of patency measurement, including endovascular interventions designed to maintain the functionality of a patent access. Secondary patency was defined as the interval from the time of the repair operation to access abandonment or the time of patency measurement, including interventions designed to re-establish the functionality of a thrombosed access. 16 Patient death and end of follow-up were censored for these analyses.
RESULTS
The demographic and other characteristics of the 209 patients are listed in Table I as fistula and graft groups. Comparing the fistula group (n ¼ 185) vs the graft group (n ¼ 24): men were 63% vs 29%, the mean age was 60.1 6 14.8 vs 63.9 6 16.0 years, diabetic patients were 54% vs 75%, the mean age of the accesses at the time of repair was 5.3 6 3.2 vs 5.0 6 4.0 years, the upper arm accesses were 69% vs 88%, the forearm accesses were 31% vs 12%, and the mean follow-up was 27.9 6 21.9 vs 14.0 6 11.6 months. A pneumatic tourniquet was used during 81% of the fistula operations and in 42% of the graft operations. To continue hemodialysis, 2% of the patients in the fistula group and 4% in the graft group required dialysis catheters. Subsequent staged aneurysm repairs were performed in 11 patients in the fistula group.
The aneurysm types 17 and surgical indications for PAR in this series are listed in Table II . In the fistula group, 95% patients had aneurysms or defects in the cannulation zone or the postarterial anastomosis segment of the fistulas, and 5% of the patients had buttonholeassociated complications. Patients in the graft group had pseudoaneurysms and graft defects. The surgical indications were access bleeding, fistula, or graft defects with plugs in imminent danger of bleeding, skin necrosis and erosion, large or thin-walled aneurysms/pseudoaneurysms in danger of rupture or other complications, or buttonhole-related bleeding or infection (Table II) . The repaired lesions were 1 to 8 cm long. After repair operations, the primary patency, assisted primary patency, and secondary patency rates of the whole access conduit for the fistula group were 45%, 96%, and 98% at 1 year, 28%, 91%, and 96% at 2 years, and 19%, 87%, and 95% at 3 years, respectively (Fig 3 ; Table III , A-C). The primary patency, assisted primary patency, and secondary patency rates of the graft group were 31%, 70%, and 96% at 6 months, and 10%, 57% and 96% at 1 year, respectively (Fig 3; Table III, D) . The low primary patency rates were primarily the result of interventions for stenoses in various segments of the access conduits, as detailed in the following paragraph and in Table IV . Because these interventions were rarely for the repair areas, the primary patency rate would not reflect the effectiveness of the repair operations.
The locations and percentages of access conduit stenoses that required endovascular interventions within the 12 months before repair operations and during followup after repair operations are listed in Table IV . For the fistula and graft groups, 78% (84 of 108) and 89% (17 of 19), respectively, of the interventions after repair operations were for recurrent lesions that existed before repair operations. Outflow vein endovascular interventions at the time of repair operations and #1 month before the repair operations were performed in 13 (7%) and 49 patients (27%), respectively, in the fistula group, and in six (25%) and six patients (25%), respectively, in the graft group. In the fistula group, nine (5%) and six (3%) patients had guided flow reduction procedures as we described before 18 for excessive access flow before and after repair operations, respectively. The PAR operations were initially successful in all patients. During the early postoperative period (<30 days), relevant complications developed in a small percentage of patients. In the fistula group (n ¼ 185), 4 patients had delayed incision healing and required débridement and reclosure with subsequent healing, 1 patient (0.5%) developed skin necrosis and the fistula was partially removed, 1 patient (0.5%) was hospitalized with bleeding 1 week after repair and the area was repaired again, with subsequent healing, 1 patient (0.5%) was hospitalized with a clotted fistula that was abandoned as dialysis access, and 8 patients (4%) were hospitalized for causes unrelated to the repair operations. No complication or hospitalization was encountered in the stage-repaired fistula group.
In the graft group (n ¼ 24), one patient (4%), who initially presented with bleeding hole over the graft, developed poor incision healing and bacteremia and the graft was subsequently removed, and one patient (4%) had bleeding that required patch repair of the graft and the graft function was restored. In the whole series, two fistulas (1%) and one graft (4%) were lost during the early postoperative period, as detailed above. No further surgical intervention of the repaired sites was needed in the subsequent follow-up visits. None of the deaths during follow-up (60 [32%] in the fistula group and 12 [50%] in the graft group) were related to the repair operations.
DISCUSSION
In this case series, we analyzed the clinical outcomes of the PAR approach in managing complications of arteriovenous fistulas and grafts related to aneurysms, pseudoaneurysms, buttonholes, or structural defects. We found that using the PAR approach could achieve high cumulative access patency rates, prolong the useful life of these arteriovenous accesses, and prevent more serious consequences from these complications. Our data also demonstrated that PAR operations could be safely performed in outpatient surgery centers under conscious sedation and local anesthesia 19 and that they were associated with a low early postoperative complication rate. Aneurysms and pseudoaneurysms are frequently seen along arteriovenous fistulas and grafts, respectively.
3,17
They usually do not affect access function or require interventions. 3 Surgical interventions need to be Primary patency 31 (5) 10 (1) 0 (0) 0 (0) Assisted primary patency 70 (12) 57 (7) 49 (6) 49 (2) Secondary patency 96 (18) 96 (12) 78 (8) 63 (2) a Given the small sample size of the graft group, only patency percentage and number of cases remaining (in parentheses) are presented.
Fig 3.
Kaplan-Meier survival analyses of the arteriovenous fistula and graft circuits after repair. The curves shown are the primary patency (PP), assisted primary patency (APP), and secondary patency (SP) of the fistula and graft groups, respectively. Further details of the patency estimates are presented in Table III. considered in these clinical scenarios: active or intermittent access bleeding, fistula or graft defects with organized thrombus plugs in imminent danger of bleeding, skin necrosis and erosion, large or thin-walled aneurysms/pseudoaneurysms in danger of rupture or other complications, or buttonhole-related bleeding or infection.
3,7
The key concern with arteriovenous access repair operations is incision healing. The skin over aneurysms and pseudoaneurysms in the cannulation zone is often scarred and under extra pressure caused by local dilation. Localized skin erosion, necrosis, or localized infection may also be present. The healing ability of scarred, eroded skin under extra pressure is much reduced; therefore, resection of these diseased tissues to achieve healthier skin margins is crucial for primary healing after repair. 6, 14 Resection of the excessive vascular wall also reduces stress on the vascular wall. 14 The repairs of buttonholes or structural defects over minimally dilated access areas are based on similar considerations. Therefore, the term partial aneurysmectomy, which was initially used, is extended to PAR to reflect the broader utility of this approach. Because there is no generally accepted definition of access aneurysms 7, 8, 17 and the local repairs for these lesions are based on similar principles, as stated earlier, clearly differentiating whether a complication is aneurysm associated or not may not be necessary. Various methods may be used to control the access circulation during repair operations. The inflow and outflow of an access are typically controlled by clamping the access via two additional separate incisions or by extending the incision of the repaired area to expose more access areas to accommodate these clamps. This approach is reliable but more invasive and may not leave sufficient access areas for continued dialysis cannulations. The pneumatic tourniquet is widely available and used by many surgeons. Its use can significantly facilitate the PAR operations and render them much less invasive. The use of the pneumatic tourniquet in vascular access operations is very safe when some simple rules are followed. 15 Recently, a newly developed silicone ring tourniquet has also been tried in access operations. 20 Changes affecting the hemodynamics of an arteriovenous access, such as outflow vein stenoses and excessive access flow, may contribute to aneurysms and pseudoaneurysms and their related complications. 13, 14, 21 Outflow vein stenoses need to be managed with endovascular angioplasty or a stent graft in the settings of aneurysmassociated complications. 13, 14 However, our data show that performing a fistulogram at the time of repair is usually not necessary unless the access conduit is significantly pressurized. Significantly excessive access flow (>2000 mL/min) can be managed with a simple guided banding approach 12, 18 and was performed in 15 patients in this series. The simplest flow reduction approach is "external Dilator-assisted banding (e-DAB)": A small transverse incision is made over the postarterial anastomosis segment; a nonabsorbable ligature (2-0 silk) is passed around the fistula vein and tied over a vascular dilator placed external to the fistula vein until the fistula flow is obliterated, and the dilator is then removed to restore fistula flow; 12F or 10F (4 or 3.3 mm in diameter) dilators are usually chosen to achieve a balance between flow reduction and preservation of fistula flow for dialysis. 18 The PAR is a targeted approach based on simple concepts and may have the following advantages: simple to perform, effective in preserving access function, reliable with predictable and long-lasting outcomes, does not introduce prosthetic materials, applicable to both fistulas and grafts, economical, minimally invasive that leaves the remaining access areas for use and spares the need for hemodialysis catheter use, and associated with a low complication rate. We therefore recommend that PAR be considered a preferred choice for managing localized access complications. 6 Some clinical considerations pertinent to the successful use of PAR approach are summarized in Table V . Various approaches have been used to manage aneurysms and pseudoaneurysms: plication, stapling, aneurysmorrhaphy with mesh, resection followed by anastomosis, interposing prosthetic or autogenous or bioengineered grafts, patch repair, fistula reconstruction, stent grafts, and, not infrequently, access ligation. 6, 7, [22] [23] [24] Each of these approaches may have its merits and limitations, and their clinical outcomes vary substantially. The presentations of the complications associated with aneurysms and pseudoaneurysms vary significantly. Ideally, the selection of a management approach for these complications is tailored to a patient's specific presentation.
The PAR approach is suitable for managing most of these complications; however, other approaches need to be considered to meet a patient's specific need. When a fistula is diffusely aneurysmal, a more extensive reconstruction approach may be needed, 11, 24 but these fistulas often may not need revision unless there are complications associated with them. 3, 24 An interposition graft may be appropriate when extensive erosion of a fistula or extensive degradation of a graft is present. 3, 25 We successfully used interposition grafts for similar clinical scenarios in several patients who were not included in this report. Endovascular stent grafts have been used for managing fistula aneurysms and graft pseudoaneurysms with variable clinical outcomes. 26, 27 The stent grafts are simpler to deploy than performing operations and do not interrupt overlying tissues. However, their potential drawbacks or limitations should be recognized: they are associated a high infection rate, especially when there are overlying soft tissue compromises 14, 26 ; it is often impossible to securely anchor them, especially in fistulas that have irregular lumens; they may cause thrombosis when misplaced; they cannot eliminate the aneurysmal dilatations and will leave lumps that may affect cannulations and the result may be cosmetically less desirable; repeated cannulations through stent grafts may be associated with an increased risk of complications; and they remain expensive. Most of the patients included in our current report had soft tissue compromises, rendering them at very high risk for infections if stent grafts were used. Of the remaining patients with thinning walls or large dilatations, stent grafts would not be suitable given the irregular fistula anatomies or could not achieve the desirable outcome that had been achieved with the PAR approach. We had mixed experiences with stent grafts in this application. On one hand, we had successfully used stent grafts to manage large fistula pseudoaneurysms secondary to dialysis cannulation injuries and graft pseudoaneurysms in some patients. On the other hand, we also had to remove stent grafts (placed by others) that caused access infections or access thrombosis. We agree with many others that stent grafts may be a useful alternative for selected clinical scenarios, but caution is warranted against their indiscriminate use in managing these diverse complications. 3, 7, 8, 14, 22 To optimize clinical outcomes, tailored selection of management options is required to meet a patient's specific needs.
CONCLUSIONS
PAR is a reliable approach for managing localized arteriovenous access complications related to aneurysms, pseudoaneurysms, buttonholes, or structural defects. Given its simplicity and reliability, we recommend PAR as a first-line choice for managing these complications of arteriovenous fistulas and a choice in selected arteriovenous graft patients.
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